clodronate disodium
ItalyDrugs containing this active substance
-
This medicine is used in women for the prevention and treatment of loss of bone density (osteoporosis) after menopause.
Form: solution for injection
Active substance Dosage clodronate disodium - lidocaine hydrochloride - ATC: M05BA02
Manufacturer: EPIFARMA S.R.L
-
It is used in women to prevent and treat the loss of bone density (osteoporosis) after menopause.
Form: solution for injection
Active substance Dosage clodronate disodium - lidocaine hydrochloride - ATC: M05BA02
Manufacturer: EPIFARMA S.R.L
-
This medicinal product is used in adults to treat the loss of bone density caused by tumors (tumor osteolysis), bone marrow tumors (multiple myeloma), and overactive parathyroid glands (primary hyperparathyroidism). It is also used in women to prevent and treat osteoporosis after menopause.
Form: solution for infusion, concentrate
Active substance Dosage clodronate disodium - lidocaine hydrochloride - ATC: M05BA02
Manufacturer: ABIOGEN PHARMA S.P.A.
-
This medicine is used in adults to treat the loss of bone density caused by tumors (tumor osteolysis), bone marrow cancer (multiple myeloma), and overactive parathyroid glands (primary hyperparathyroidism). It is also used in women to prevent and treat osteoporosis after menopause.
Form: solution for infusion, concentrate
Active substance Dosage clodronate disodium - lidocaine hydrochloride monohydrate - ATC: M05BA02
Manufacturer: ABIOGEN PHARMA S.P.A.
-
It is used in women to prevent and treat the loss of bone density (osteoporosis) after menopause.
Form: solution for injection
Active substance Dosage clodronate disodium - lidocaine hydrochloride - ATC: M05BA02
Manufacturer: FG S.R.L.
-
It is used in women for the prevention and treatment of loss of bone density (osteoporosis) after menopause.
Form: solution for injection
Active substance Dosage clodronate disodium - lidocaine hydrochloride - ATC: M05BA02
Manufacturer: I.G. FARMACEUTICI DI IRIANNI GIUSEPPE
-
It is used in women for the prevention and treatment of loss of bone density (osteoporosis) after menopause.
Form: solution for injection
Active substance Dosage clodronate disodium - lidocaine hydrochloride - ATC: M05BA02
Manufacturer: IPSO PHARMA S.R.L.
-
It is used in women for the prevention and treatment of loss of bone density (osteoporosis) after menopause.
Form: solution for injection
Active substance Dosage clodronate disodium - lidocaine hydrochloride - ATC: M05BA02
Manufacturer: PHARMEG S.R.L.
-
This medicine is used in adults to treat the loss of bone density caused by tumors (tumor osteolysis), multiple myeloma (bone marrow cancer), and overactive parathyroid glands (primary hyperparathyroidism). It is also indicated in women for the prevention and treatment of osteoporosis after menopause.
Form: solution for infusion, concentrate
Active substance Dosage clodronate disodium - lidocaine hydrochloride - ATC: M05BA02
Manufacturer: SPA SOCIETA' PRODOTTI ANTIBIOTICI S.P.A.
-
This medicinal product is used by adults to treat the loss of bone density caused by tumors (tumor-related osteolysis), bone marrow cancer (multiple myeloma), and overactive parathyroid glands (primary hyperparathyroidism). In women, it is also used to prevent and treat osteoporosis after menopause.
Form: solution for injection
Active substance Dosage clodronate disodium - lidocaine hydrochloride - ATC: M05BA02
Manufacturer: I.B.N. SAVIO S.R.L
-
It is used in women for the prevention and treatment of loss of bone density (osteoporosis) after menopause.
Form: solution for injection
Active substance Dosage clodronate disodium - lidocaine hydrochloride - ATC: M05BA
Manufacturer: I.B.N. SAVIO S.R.L